Bladder Cancer Indication Withdrawn for Durvalumab ...Middle East

Medscape - News
AstraZeneca is withdrawing durvalumab's indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit. Medscape Medical News

Hence then, the article about bladder cancer indication withdrawn for durvalumab was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bladder Cancer Indication Withdrawn for Durvalumab )

Apple Storegoogle play

Last updated :

Also on site :